=Diagnostic tools and treatments, continued3=

3. (LDN continued)
A big trial would be necessary to prove the effectiveness of LDN, but "there is little incentive for pharmaceutical companies to conduct this research as naltrexone is inexpensive and off-patent." (copypaste from the wikipedia articel on low dose Naltrezone)

#longcovid #longcovidtreatment #bigpharma #disappointednotsurprised